Double-blind, randomized, clinical trial of topiramate versus sodium valproate for the treatment of bipolar disorder in adolescents
Pakistan Journal of Medical Sciences. 2009; 25 (2): 247-252
in English
| IMEMR
| ID: emr-92412
ABSTRACT
To study the efficacy and safety of Topiramate versus Sodium Valproate for the Treatment of Bipolar Disorder in Adolescents. One hundred twenty adolescents [aged 12-18] with an admission diagnosis of bipolar I disorder, manic or mixed episode were enrolled from the Adolescent Ward at Ebn-e-Sina Psychiatric Center of Mashhad University. They were assigned to receive 8 weeks of double-blinded, flexibly dosed treatment with topiramate or sodium valproate. The primary efficacy measure was the mean change from baseline to endpoint in the Young Mania Rating Scale [YMRS]. Sodium Valproate was superior to topiramate. The YMRS scores decreased significantly in both groups. However, when efficacy of topiramte was analyzed, only 18.64% of the patients showed YMRS scores decrease more than 50% from baseline. This study does not support the efficacy of topiramate as monotherapy in acute mania or mixed episodes in adolescents with bipolar I disorder and sodium valproate was found superior to topiramate
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Antipsychotic Agents
/
Double-Blind Method
/
Valproic Acid
/
Adolescent
/
Treatment Outcome
/
Fructose
/
Gamma-Aminobutyric Acid
/
Lithium
/
Anticonvulsants
Type of study:
Controlled clinical trial
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Pak. J. Med. Sci.
Year:
2009
Similar
MEDLINE
...
LILACS
LIS